Show/hide main menu

News

Wednesday 17th October 2018

Wolfson CARD receives two MRC grants to combat demyelination and fibromyalgia

Wolfson CARD receives two MRC grants to combat demyelination and fibromyalgia
Description
Two new grants have been awarded to explore the pathophysiological basis of pain Fibromyalgia and demyelination. Myelin damage, which is prevalent in many neurological diseases, is a major social and economic cost to society. But we still do not fully understand the processes that lead to myelin damage. Fibromyalgia, causing pain, sleep disturbances and memory problems, affects more than 2% of the general population but the mechanisms responsible for the syndrome are unknown.
Date:
17 October 2018
Friday 13th July 2018

IoPPN researchers awarded prestigious EU Horizon 2020 Grant

IoPPN researchers awarded prestigious EU Horizon 2020 Grant
Description
Scientists from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have been awarded a prestigious EU Horizon 2020 Marie Skłodowska-Curie Initial Training Network grant, in collaboration with 4 academic institutions, 2 pharmaceutical companies, 3 SMEs, and 1 non-profit research charity, from four European countries (Austria, Germany, Sweden, and the UK).
Date:
13 July 2018
Thursday 28th September 2017

A novel RARb agonist for spinal cord injury receives funding for a phase 1 trial from the MRC-DPFS

A novel RARb agonist for spinal cord injury receives funding for a phase 1 trial from the MRC-DPFS
Description
£2.2 million DPFS-MRC award for Phase 1 trial
Date:
28 September 2017
Friday 19th May 2017

New Innovative Medicine Initiative funding award

New Innovative Medicine Initiative funding award
Description
Prof Stephen McMahon and Dr Franziska Denk from the Wolfson Centre for Age-Related Diseases have been awarded EUR 450,000, as part of a new European research consortium funded by the Innovative Medicine Initiative (IMI2).
Date:
19 May 2017
Wednesday 22nd March 2017

Joseph Bateman awarded funding to study rare genetic disease

Joseph Bateman awarded funding to study rare genetic disease
Description
Dr Joseph Bateman from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has been awarded a $484,000 grant from the US Department of Defense for a study into Tuberous Sclerosis Complex, a rare genetic disease.
Date:
22 March 2017
Displaying 1 to 5 of 16
Previous 1 2 3 4 Next
Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2019 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454